Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-19

FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (Meitheal Pharmaceuticals Inc)

View source ↗

Summary

FDA approved a supplemental application for Leuprolide acetate from Meitheal Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leuprolide acetate (Leuprolide acetate)

Snippet

SUPPL AP for LEUPROLIDE ACETATE (LEUPROLIDE ACETATE)